Zhongnan Medical Journal Press

Home Results

A total of 24 result was found. Results that relate to Immunotherapy

A case report of immunotherapy-related breast reactive capillary endothelial proliferation

Published on New Medicine 2023,33(1):74-77.
10495 times 2676 times

Chen JIE Jing YU Ru-Meng LI Jun GONG Cong-Hua XIE

Reactive capillary endothelial proliferation Breast Immunotherapy Camrelizumab
Details
Progress in molecular pathology and targeted therapy of pulmonary sacromatiod carcinoma

Published on New Medicine 2021,31(1):138-144.
19386 times 5376 times

Yu-Wei DING Xiu-Jun TANG Yi CHENG Ning ZHU Shan-Shan WENG Ying YUAN

Pulmonary sacromatiod carcinoma Targeted therapy Molecular pathology Precision medicine Immunotherapy
Details
Natural killer cell in the development and treatment of head and neck squamous cell carcinoma

Published on New Medicine 2021,31(1):33-41.
14204 times 4574 times

Lu-Ming WANG Shang XIE

Nature killer cells Head and neck squamous cell carcinoma Immunotherapy
Details
Current perspectives on tertiary lymphoid structures and PD-1/PD-L1 signaling pathway in the immunotherapy of hepatocellular carcinoma

Published on New Medicine 2023,33(5):373-380.
10630 times 2660 times

Hao-Dong QIAO Yi-Fan LIU Ze LIANG Huai-Bin GUO

Hepatocellular carcinoma Immunotherapy PD-1/PD-L1 signaling pathway Tertiary lymphoid structures
Details
A case of severe immune liver injury caused by pembrolizumab and rechallenge

Published on Chinese Journal of Pharmacoepidemiology 2024,33(2):212-217.
9878 times 2596 times

LIU Min YANG Limei YIN Yue ZHAO Bingqing

Pembrolizumab Immune related liver injury Rechallenge of immunotherapy
Details
Prognosis prediction and regulatory mechanism of cuproptosis-associated long non-coding RNA in laryngeal cancer

Published on Journal of Mathematical Medicine 2024,37(4):266-275.
12927 times 2312 times

LI Shuzhen ZAN Yuxin

Cuproptosis lncRNA Laryngeal cancer Prognosis Immunotherapy
Details
PD-1 inhibitor combined with chemotherapy in the treatment of metastatic nasopharyngeal carcinoma: a case report

Published on Journal of Mathematical Medicine 2024,37(5):392-397.
10790 times 2426 times

CHENG Yanshuang WANG Juan JIN Jieying WU Qiuji ZHONG Yahua

Nasopharyngeal carcinoma PD-1 inhibitor Immunotherapy Chemotherapy
Details
Progress of clinical research on immunotherapy and antibody-drug conjugates for the treatment of triple-negative breast cancer

Published on Frontiers in Pharmaceutical Sciences 2024,27(5):901-908.
11115 times 1881 times

YANG Dan WANG Jinxiu MAO Dahua

Triple-negative breast cancer Immunotherapy Antibody-drug conjugates Clinical trials Immune checkpoint inhibitors Chemotherapy
Details
Research progress of immune checkpoint inhibitors in the treatment of glioblastoma

Published on New Medicine 2024,34(5):593-602.
12214 times 2707 times

JIA Xiaorong ZHANG Gong

Glioblastoma Immunotherapy Immunocyte Immune checkpoint inhibitors
Details
Analysis of the prognostic value of NLR in the treatment of PD-1 inhibitors in patients with HER2-negative advanced gastric cancer

Published on Frontiers in Pharmaceutical Sciences 2024,27(6):1063-1071.
8317 times 1831 times

DOU Yalin CHENG Weili SUN Mingqi WU Shuanghong YANG Tingting LI Dapeng

Advanced gastric cancer Immunotherapy Neutrophils/lymphocytes Prognosis Chemotherapy human Epdermal growth factor receptor
Details
Diffuse large B-cell type Richter syndrome in 2 cases and literature review

Published on Journal of Mathematical Medicine 2024,37(9):701-708.
14097 times 2147 times

SHEN Jifu ZHOU Qing CHEN Xiaoyun YAN Zhimin

Chronic lymphocytic leukemia Diffuse large B-cell lymphoma Richter syndrome Stem cell transplantation Chimeric antigen receptor T cell Immunotherapy Clinical diagnosis
Details
Research progress in targeted PD-L1 related inhibitors and degraders

Published on Frontiers in Pharmaceutical Sciences 2024,28(2):310-320.
12151 times 1892 times

XIAO Yao ZHU Yawen

Immunotherapy Degraders Small molecule inhibitors Programmed death-1/programmed ligand death-1 Proteolysis-targeting chimeras Lysosome-targeting chimeras technologies
Details
Research hotspots and future trends of drug resistance mechanism in treatment of renal cell carcinoma based on bibliometric analysis

Published on Chinese Journal of Pharmacoepidemiology 2024,33(11):1276-1295.
12806 times 2497 times

ZHENG Xinyi XU Jiajun QIU Xiaoyan

Renal cell carcinoma Drug resistance Targeted therapy Immunotherapy Bibliometric analysis Visualization
Details
Construction of a nomogram model for the prognosis of advanced non-small cell lung cancer patients treated with microwave ablation combined with immunotherapy based on inflammatory and nutritional indicators

Published on Journal of Mathematical Medicine 2024,37(12):899-911.
14486 times 2274 times

LI Chen XIANG Shiqiang

Non-small cell lung cancer Microwave ablation Immunotherapy Nutritional indicators Inflammatory indicators Nomogram model
Details
Literature analysis of adverse reactions to multiple organ injury induced by camrelizumab

Published on Frontiers in Pharmaceutical Sciences 2024,28(4):648-656.
12149 times 1711 times

ZHANG Yang SU Wenyang GAO Yue

Camrelizumab Multiple organ injury Adverse reactions Literature system analysis Immunotherapy Programmed death protein 1
Details